BVS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 birž. 2024 @ 19:41):
Our systems believe the stock currently is overvalued by -0.98% compare to its pairs and should correct downwards.

Stats
Dzisiejszy wolumen	230 627
Średni wolumen	319 466
Kapitalizacja rynkowa	354.88M
EPS	$-0.0721 ( Q1 \| 2024-05-07 )
Następna data zysków	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-16.85 (Sector) 42.63 (Industry) 43.86
ATR14	$0.0110 (0.20%)

ABMD 0.00%

AMIX -2.65%

BBLGW -19.30%

BVS 1.46%

COCH 0.43%

DHAI -4.85%

DHAIW 0.00%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -2.26%

HSCSW 19.64%

IINNW -27.42%

INVO -6.67%

LFWD 0.49%

MDAI 1.82%

MGRM -2.86%

MXCT -2.57%

NVNOW -32.98%

NXL 28.19%

NXLIW -25.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ -4.76%

PETVW 0.00%

QTI 1.57%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-21	Singleton Mark Leonard	Sell	9 219	Class A Common Stock
2024-06-21	D'adamio Anthony	Sell	5 904	Class A Common Stock
2024-06-21	Church Katrina J	Sell	2 559	Class A Common Stock
2024-06-20	Singleton Mark Leonard	Buy	31 000	Class A Common Stock
2024-06-20	Singleton Mark Leonard	Sell	31 000	Restricted Stock Units

INSIDER POWER
8.89
Last 95 transactions
Buy: 3 061 970 \| Sell: 3 180 178

Korelacja (AI algo v.1.1b): Overvalued: -0.98% $5.55 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: -0.16 (neutral)

Krótki: -0.80 (moderate negative)

Signal:(65.53) Neutral

Bioventus Inc. Korelacja

10 Najbardziej pozytywne korelacje
ADEA	0.927
MXCT	0.907
GFGF	0.894
INTR	0.894
BDAFX	0.891
JGLO	0.89
JHEQX	0.89
FCIRX	0.888
JHQAX	0.888
CCLDP	0.886

10 Najbardziej negatywne korelacje
OZEM	-1
GECCI	-0.893
NEWZ	-0.892
CCSB	-0.889
BKHA	-0.864
GHIXW	-0.84
ERNZ	-0.826
BKHAU	-0.825
CRGO	-0.817

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bioventus Inc. Korelacja - Waluta/Towar

0.71
( moderate )

0.16
( neutral )

0.00
( neutral )

0.51
( weak )

0.01
( neutral )

-0.12
( neutral )

Bioventus Inc. Finanse

Annual	2023
Przychody:	$512.35M
Zysk brutto:	$319.35M (62.33 %)
EPS:	$-2.49

FY	2023
Przychody:	$512.35M
Zysk brutto:	$319.35M (62.33 %)
EPS:	$-2.49

FY	2022
Przychody:	$512.12M
Zysk brutto:	$331.08M (64.65 %)
EPS:	$-3.48

FY	2021
Przychody:	$130.41M
Zysk brutto:	$87.77M (67.30 %)
EPS:	$-0.00966

Financial Reports:

No articles found.

Bioventus Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bioventus Inc.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body\'s natural healing process in the United States and internationally. The company\'s product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company\'s restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician\'s office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.